CSBR
Champions Oncology Inc
5.00$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.1% | 77.7% | 63.0% | 52.1% | 52.7% | 52.9% | 52.3% | 48.1% | 54.8% | 58.6% | 49.9% | 52.0% | |
| 13.9% | 22.3% | 37.0% | 47.9% | 47.3% | 47.1% | 47.7% | 51.9% | 45.2% | 41.4% | 50.1% | 48.0% | |
| 54.7% | 37.5% | 27.9% | 21.7% | 17.7% | 18.2% | 17.5% | 19.1% | 21.4% | 19.0% | 12.0% | 15.3% | |
| 60.3% | 46.3% | 32.2% | 20.1% | 17.3% | 20.6% | 15.9% | 18.6% | 19.0% | 22.1% | 16.4% | 18.8% | |
| 163.2% | 114.6% | 81.2% | 54.6% | 46.3% | 53.1% | 46.9% | 50.6% | 53.4% | 55.2% | 41.6% | 49.9% | |
| -149.4% | -92.3% | -44.2% | -6.7% | 1.0% | -6.0% | 0.9% | 1.2% | -8.3% | -13.8% | 8.5% | -1.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 2.2% | 0.2% | 0.0% | – | 0.1% | 0.0% | – | |
| -146.8% | -92.6% | -44.5% | -7.1% | 0.9% | -6.1% | 1.1% | 1.2% | -9.8% | -14.6% | 8.1% | -1.6% | |
| 1.4% | 0.8% | 0.1% | 0.2% | 0.4% | 0.4% | 0.2% | 0.1% | 0.1% | -0.1% | -0.1% | 0.4% | |
| -148.3% | -93.4% | -44.7% | -7.3% | 0.5% | -6.5% | 0.9% | 1.1% | -9.9% | -14.5% | 8.3% | -2.0% | |
| -146.9% | -90.9% | -43.1% | -4.9% | 3.2% | -2.4% | 3.8% | 4.5% | -5.6% | -10.8% | 11.0% | 0.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.